PTE News and Press, PolarityTE Inc. From 05/14/21

Gainers: LifeMD (LFMD) +26%, Bionano Genomics (BNGO) +21%, Atea Pharmaceuticals (AVIR) +17%, DermTech (DMTK) +16%, Aesthetic Medical International (AIH) +12%.Losers: CorMedix (CRMD) -27%, Solid Biosciences (SLDB) -22%, PolarityTE (PT...

CorMedix (CRMD) -27% on Q1 earnings releaseIZEA Worldwide (IZEA) -25% on Q1 earnings releasePlantronics (PLT) -22% on Q4 earnings releaseMonaker Group (MKGI) -18% after pricing equity offering at $2.50.Meten EdtechX Education (METX) -18%.Eloxx Pharmaceu...

PolarityTE (PTE) reports financial results for the first quarter ended March 31, 2021.Q1 total revenues increased by 405% to $4.71M compared to $0.93M for the same period in 2020 and, up 31% QoQ.The increase in net revenues for sale of products was the result of a sales strategy adopted in Ma...

The following slide deck was published by PolarityTE, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: PolarityTE, Inc. 2021 Q1 - Results - Earnings Call Presentation

PolarityTE, Inc. (PTE) Q1 2021 Earnings Conference Call May 13, 2021, 04:30 PM ET Company Participants Rich Haerle - VP of IR David Seaburg - CEO Richard Hague - President and COO Jake Patterson - Interim CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald Sean King - H.C. Wai...

PolarityTE (PTE): Q1 Non-GAAP EPS of -$0.12 misses by $0.01; GAAP EPS of -$0.24 misses by $0.13.Revenue of $4.71M (+406.5% Y/Y) beats by $1.41M.Shares -17%.Press Release For further details see: PolarityTE EPS misses by $0.01, beats on revenue

First Quarter 2021 Total Revenues of $4.71 million Compared to $3.59 million in Fourth Quarter of 2020 PolarityTE to host conference call and webcast today, May 13, 2021 at 4:30 p.m. ET PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerat...

Top Penny Stocks to Watch With Important Announcements With May well underway, penny stocks are very much still in focus. But, several industries are seeing more attention than others. Right now, this includes biotech stocks , blockchain stocks , and others. While penny stocks...

PolarityTE (PTE) soars 25% premarket after announcing preliminary topline data demonstrating that a randomized controlled trial evaluating treatment of Diabetic Foot Ulcers with SkinTE plus standard of care ((SOC)) vs SOC alone met the primary endpoint of wound closure at 12 weeks a...

Reports Peer-Reviewed Publication of Interim Results from Diabetic Foot Ulcer Trial in International Wound Journal PolarityTE, Inc. (Nasdaq: PTE) today announced preliminary topline data demonstrating that a multi-center randomized controlled trial evaluating treatment o...